Email RIS file
Bookmark
Report an Issue

The neuroethics of biomarkers : what the development of bioprediction means for moral responsibility, justice, and the nature of mental disorder / edited by Matthew L. Baum

Published
New York, NY : Oxford University Press, 2016.
Physical Description
1 online resource
Additional Creators
Baum, Matthew L.
Access Online

Availability

I Want It
I Want It

Finding items...

Series
Contents
Machine generated contents note: 1.The Biomedical Promise of Biomarkers -- 2.Bioprediction of Brain Disorder: Definitions and Scope -- pt. I Reorientation of the Concept of Disorder -- 3."There Is More Light Here": Re-illuminating the Categories of Mental Illness -- 4.The Probability Dysfunction -- 5.The Practical Ethics of Predictive Markers in Diagnosis: Can Risk Banding Address the Ethical Controversy Surrounding "Psychosis Risk Syndrome" and "Preclinical Alzheimer's Disease"? -- pt. II Bioprediction and Moral Responsibility -- 6.Enhanced Responsibility: Foreseeability and New Obligations to Others -- 7.Reduced Responsibility: Distinguishing Conditions in Which Biomarkers Properly Reduce Legal Responsibility -- pt. III Bioprediction and Society -- 8.Bioprediction and Priority.
Summary
Neuroscientists are mining nucleic acids, fluids, and brain images for biomarkers of risk of brain disorders. This book brings clarity to several debates on the neuroethics of biomarkers by arguing for the abandonment of a categorical concept of disorder (sick vs. well) and the adoption of an explicitly probabilistic one.
Subject(s)
ISBN
9780190236281 (ebook)
Bibliography Note
Includes bibliographical references and index.
View MARC record | catkey: 28935517